Total Payments
$327,857
2024 Payments
$39,063
Companies
17
Transactions
294
Medicare Patients
649
Medicare Billing
$106,881
Payment Breakdown by Category
Other$253,996 (77.5%)
Travel$43,243 (13.2%)
Consulting$24,422 (7.4%)
Food & Beverage$5,997 (1.8%)
Research$119.22 (0.0%)
Education$80.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $240,976 | 70 | 73.5% |
| Travel and Lodging | $43,243 | 128 | 13.2% |
| Consulting Fee | $24,422 | 13 | 7.4% |
| Honoraria | $7,740 | 2 | 2.4% |
| Food and Beverage | $5,997 | 76 | 1.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,280 | 2 | 1.6% |
| Unspecified | $119.22 | 1 | 0.0% |
| Education | $80.50 | 2 | 0.0% |
Payments by Type
General
$327,738
293 transactions
Research
$119.22
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $212,332 | 172 | $0 (2024) |
| Exelixis Inc. | $65,245 | 80 | $0 (2024) |
| Seagen Inc. | $20,071 | 16 | $0 (2023) |
| Amgen Inc. | $11,158 | 6 | $0 (2019) |
| PFIZER INC. | $8,400 | 2 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $6,416 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $2,158 | 2 | $0 (2023) |
| Rigel Pharmaceuticals, Inc. | $1,000 | 1 | $0 (2020) |
| BeiGene USA, Inc. | $486.67 | 1 | $0 (2023) |
| Varian Medical Systems, Inc. | $142.51 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,063 | 24 | Ipsen Biopharmaceuticals, Inc ($22,701) |
| 2023 | $82,986 | 80 | Ipsen Biopharmaceuticals, Inc ($36,476) |
| 2022 | $37,007 | 36 | Ipsen Biopharmaceuticals, Inc ($20,779) |
| 2021 | $64,159 | 35 | Ipsen Biopharmaceuticals, Inc ($49,290) |
| 2020 | $33,820 | 33 | Ipsen Biopharmaceuticals, Inc ($24,014) |
| 2019 | $35,903 | 38 | Ipsen Biopharmaceuticals, Inc ($24,814) |
| 2018 | $34,003 | 45 | Ipsen Biopharmaceuticals, Inc ($33,361) |
| 2017 | $915.94 | 3 | Ipsen Biopharmaceuticals, Inc ($897.00) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/16/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $763.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/05/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $95.63 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/17/2024 | Exelixis Inc. | CABOMETYX (Drug) | Honoraria | Cash or cash equivalent | $1,650.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/11/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,610.00 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,090.00 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $607.63 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $181.47 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $145.40 | General |
| Category: Oncology | ||||||
| 06/03/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $126.52 | General |
| Category: Oncology | ||||||
| 06/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $174.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 04/30/2024 | PFIZER INC. | TUKYSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,000.00 | General |
| Category: Oncology | ||||||
| 04/30/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,980.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 04/30/2024 | PFIZER INC. | TUKYSA (Drug) | Travel and Lodging | In-kind items and services | $1,399.81 | General |
| Category: Oncology | ||||||
| 04/03/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,090.00 | General |
| Category: Oncology | ||||||
| 03/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $206.41 | General |
| Category: Oncology | ||||||
| 03/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Oncology | ||||||
| 03/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Oncology | ||||||
| 03/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Oncology | ||||||
| 03/01/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $748.20 | General |
| Category: Oncology | ||||||
| 03/01/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,220.00 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $295.00 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $84.90 | General |
| Category: Oncology | ||||||
| 12/07/2023 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $57.82 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors | Seattle Genetics, Inc. | $119.22 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 95 | 206 | $57,998 | $18,487 |
| 2022 | 7 | 204 | 392 | $107,247 | $33,188 |
| 2021 | 7 | 218 | 438 | $131,771 | $41,190 |
| 2020 | 6 | 132 | 183 | $53,439 | $14,016 |
Total Patients
649
Total Services
1,219
Medicare Billing
$106,881
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 27 | 52 | $15,756 | $5,161 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 42 | $12,726 | $4,453 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 52 | $11,256 | $3,668 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 44 | $9,460 | $3,094 | 32.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 16 | $8,800 | $2,110 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 65 | $19,695 | $6,787 | 34.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 66 | $18,744 | $5,280 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 67 | $14,405 | $4,995 | 34.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $11,550 | $3,243 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 33 | $9,999 | $3,165 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 44 | $9,460 | $3,129 | 33.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 51 | $10,047 | $2,826 | 28.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $7,803 | $2,205 | 28.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 28 | 28 | $5,544 | $1,559 | 28.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 47 | 172 | $48,848 | $14,013 | 28.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 46 | $25,300 | $7,265 | 28.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 48 | $14,544 | $5,594 | 38.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 50 | $10,750 | $3,881 | 36.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 31 | $9,393 | $3,563 | 37.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 19 | 19 | $8,721 | $2,790 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 41 | $8,077 | $2,325 | 28.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 30 | 31 | $6,138 | $1,760 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 53 | $15,455 | $4,349 | 28.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 41 | 52 | $18,056 | $3,961 | 21.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $6,367 | $1,648 | 25.9% |
About Dr. Ravi Paluri, MD
Dr. Ravi Paluri, MD is a Hematology & Oncology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2009. The National Provider Identifier (NPI) number assigned to this provider is 1801030226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ravi Paluri, MD has received a total of $327,857 in payments from pharmaceutical and medical device companies, with $39,063 received in 2024. These payments were reported across 294 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($240,976).
As a Medicare-enrolled provider, Paluri has provided services to 649 Medicare beneficiaries, totaling 1,219 services with total Medicare billing of $106,881. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Winston Salem, NC
- Active Since 04/29/2009
- Last Updated 07/17/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1801030226
Products in Payments
- ONIVYDE (Drug) $100,410
- Onivyde (Drug) $86,346
- CABOMETYX (Drug) $41,011
- TUKYSA (Drug) $28,471
- Cabometyx (Drug) $18,619
- SOMATULINE DEPOT (Drug) $18,437
- Vectibix (Biological) $11,158
- Xermelo (Drug) $6,416
- Somatuline Depot (Drug) $6,191
- IMFINZI (Biological) $2,055
- Tavalisse (Drug) $1,000
- BRUKINSA (Drug) $486.67
- TrueBeam (Device) $142.51
- LUTATHERA (Drug) $124.24
- Avastin (Biological) $110.92
- NINLARO (Drug) $34.73
- Yescarta (Drug) $22.55
- THERASPHERE - BIO (Device) $18.94
- Creon (Drug) $17.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Winston Salem
Dr. Angela Alistar, Md, MD
Hematology & Oncology — Payments: $468,976
Hematology & Oncology $468,976
Caio Max Rocha Lima, Md, MD
Hematology & Oncology — Payments: $361,035
Hematology & Oncology $361,035
Dr. Franklin Chen, M.d, M.D
Hematology & Oncology — Payments: $329,365
Hematology & Oncology $329,365
Dr. Timothy Pardee, M.d., Ph.d, M.D., PH.D
Hematology & Oncology — Payments: $120,125
Hematology & Oncology $120,125
Leon Bernal-Mizrachi, Md, MD
Hematology & Oncology — Payments: $46,070
Hematology & Oncology $46,070
John Mckay, D.o, D.O
Hematology & Oncology — Payments: $12,986
Hematology & Oncology $12,986